These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 20980593)

  • 1. S-nitrosylation of cyclin-dependent kinase 5 (cdk5) regulates its kinase activity and dendrite growth during neuronal development.
    Zhang P; Yu PC; Tsang AH; Chen Y; Fu AK; Fu WY; Chung KK; Ip NY
    J Neurosci; 2010 Oct; 30(43):14366-70. PubMed ID: 20980593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin-dependent kinase 5 is required for normal cerebellar development.
    Kumazawa A; Mita N; Hirasawa M; Adachi T; Suzuki H; Shafeghat N; Kulkarni AB; Mikoshiba K; Inoue T; Ohshima T
    Mol Cell Neurosci; 2013 Jan; 52():97-105. PubMed ID: 23085039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of CDK5 in Tumours and Tumour Microenvironments.
    Do PA; Lee CH
    Cancers (Basel); 2020 Dec; 13(1):. PubMed ID: 33396266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cdk5: a multifaceted kinase in neurodegenerative diseases.
    Cheung ZH; Ip NY
    Trends Cell Biol; 2012 Mar; 22(3):169-75. PubMed ID: 22189166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S-Nitrosylation activates Cdk5 and contributes to synaptic spine loss induced by beta-amyloid peptide.
    Qu J; Nakamura T; Cao G; Holland EA; McKercher SR; Lipton SA
    Proc Natl Acad Sci U S A; 2011 Aug; 108(34):14330-5. PubMed ID: 21844361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant protein S-nitrosylation contributes to the pathophysiology of neurodegenerative diseases.
    Nakamura T; Prikhodko OA; Pirie E; Nagar S; Akhtar MW; Oh CK; McKercher SR; Ambasudhan R; Okamoto S; Lipton SA
    Neurobiol Dis; 2015 Dec; 84():99-108. PubMed ID: 25796565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDK5 activator protein p25 preferentially binds and activates GSK3β.
    Chow HM; Guo D; Zhou JC; Zhang GY; Li HF; Herrup K; Zhang J
    Proc Natl Acad Sci U S A; 2014 Nov; 111(45):E4887-95. PubMed ID: 25331900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the SIK2-p35-PJA2 complex in pancreatic β-cell functional compensation.
    Sakamaki J; Fu A; Reeks C; Baird S; Depatie C; Al Azzabi M; Bardeesy N; Gingras AC; Yee SP; Screaton RA
    Nat Cell Biol; 2014 Mar; 16(3):234-44. PubMed ID: 24561619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p10, the N-terminal domain of p35, protects against CDK5/p25-induced neurotoxicity.
    Zhang L; Liu W; Szumlinski KK; Lew J
    Proc Natl Acad Sci U S A; 2012 Dec; 109(49):20041-6. PubMed ID: 23151508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective autophagy in Parkinson's disease: role of oxidative stress.
    Janda E; Isidoro C; Carresi C; Mollace V
    Mol Neurobiol; 2012 Dec; 46(3):639-61. PubMed ID: 22899187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cdk5 protein inhibition and Aβ42 increase BACE1 protein level in primary neurons by a post-transcriptional mechanism: implications of CDK5 as a therapeutic target for Alzheimer disease.
    Sadleir KR; Vassar R
    J Biol Chem; 2012 Mar; 287(10):7224-35. PubMed ID: 22223639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of cyclin-dependent kinase 5 depletion on poly(ADP-ribose) polymerase activity and responses to radiation.
    Bolin C; Boudra MT; Fernet M; Vaslin L; Pennaneach V; Zaremba T; Biard D; Cordelières FP; Favaudon V; Mégnin-Chanet F; Hall J
    Cell Mol Life Sci; 2012 Mar; 69(6):951-62. PubMed ID: 21922195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cdk5-mediated phosphorylation of endophilin B1 is required for induced autophagy in models of Parkinson's disease.
    Wong AS; Lee RH; Cheung AY; Yeung PK; Chung SK; Cheung ZH; Ip NY
    Nat Cell Biol; 2011 May; 13(5):568-79. PubMed ID: 21499257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant protein s-nitrosylation in neurodegenerative diseases.
    Nakamura T; Tu S; Akhtar MW; Sunico CR; Okamoto S; Lipton SA
    Neuron; 2013 May; 78(4):596-614. PubMed ID: 23719160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S-nitrosylation of Cdk5: potential implications in amyloid-β-related neurotoxicity in Alzheimer disease.
    Qu J; Nakamura T; Holland EA; McKercher SR; Lipton SA
    Prion; 2012; 6(4):364-70. PubMed ID: 22874667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cdk5 activation promotes Cos-7 cells transition towards neuronal-like cells.
    Bao L; Lan XM; Zhang GQ; Bao X; Li B; Ma DN; Luo HY; Cao SL; Liu SY; Jing E; Zhang JZ; Zheng YL
    Transl Neurosci; 2023 Jan; 14(1):20220318. PubMed ID: 37901140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the Cysteine Redox Proteome in Parkinson's Disease: The Role of Glutathione Precursors and Beyond.
    Martinez-Banaclocha MA
    Antioxidants (Basel); 2023 Jun; 12(7):. PubMed ID: 37507913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Focusing on cyclin-dependent kinases 5: A potential target for neurological disorders.
    Tian Z; Feng B; Wang XQ; Tian J
    Front Mol Neurosci; 2022; 15():1030639. PubMed ID: 36438186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hidden networks of aberrant protein transnitrosylation contribute to synapse loss in Alzheimer's disease.
    Lipton SA
    Free Radic Biol Med; 2022 Nov; 193(Pt 1):171-176. PubMed ID: 36243209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multitargeting the Action of 5-HT
    Czarnota-Łydka K; Kucwaj-Brysz K; Pyka P; Haberek W; Podlewska S; Handzlik J
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.